U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07899424) titled 'Microbiota Modulation for Psychiatry Patients' on Oct. 08.
Brief Summary: The investigators aim to confirm pilot study findings (REB 119638) on the effects of delayed release apple cider vinegar (drACV). The investigators aimed to determine the feasibility that the acetate in ACV would counteract the problematic weight gain and metabolic side effects associated with the most common psychiatric medications. Our pilot study recruited 11 participants from the First Episode Mood and Anxiety Program (FEMAP) who had experienced (by self-report) weight gain concurrent with medication use. The investigators found that drACV was well tolerat...